NCT05146323View on ClinicalTrials.gov

Optimization of 99mTc-Sestamibi Activities in SPECT/CT Myocardial Perfusion Imaging

CompletedOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

September 24, 2021

Conditions
Coronary Heart Disease
Trial Locations (1)

57085

CHR Metz Thionville, Metz

All Listed Sponsors
lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT05146323 - Optimization of 99mTc-Sestamibi Activities in SPECT/CT Myocardial Perfusion Imaging | Biotech Hunter | Biotech Hunter